Fortrea (FTRE) 44th Annual J.P. Morgan Healthcare Conference summary

Company Background, Strategic Positioning, and Market Outlook

• Spun out from Labcorp in 2023, with a heritage tracing back to Covance, focusing on simplifying drug development complexities and accelerating clinical trials for clients, patients, and sites.

• Operates as a pure-play global CRO with over 30 years of experience, a diversified client base, and a global workforce of approximately 14,500 employees across 100 countries.

• Addressable market is projected at ~$40B, with pharma R&D spend expected to grow at a 3.5% CAGR through 2030 and outsourced clinical development spend anticipated to grow ~4%.

• Oncology is the leading therapeutic area, with growth in immunology, endocrinology/metabolism, and neurology.

• Recognized for leadership in clinical pharmacology and full-service clinical trial management, with a strong focus on customer intimacy.

Operational Capabilities, Technology, and Execution

• Offers comprehensive Phase I–IV clinical trial services, managing over 5,900 trials in five years and leveraging deep expertise in high-growth therapeutic areas.

• Emphasizes modernizing study delivery through AI, machine learning, automation, predictive analytics, and digital-first transformation initiatives such as mobile apps and enhanced data management.

• Integrated clinical pharmacology solution includes four research units and ~1,000 dedicated resources.

• Focused on commercial excellence (reach, relevance, repeat), operational excellence (project management, digitization), and financial excellence (cost discipline, margin improvement).

• Operational changes include right-sizing, SG&A effectiveness, and enhanced project management to ensure consistent delivery.

Client Base and Commercial Performance

• Revenue mix in Q3 2025: 57% large pharma, 43% biotech and other segments; top 10 clients represent ~60% of revenue.

• Bookings mix is balanced between large pharma and biotech, with Net Promoter Scores improving steadily since 2023.

• Strategic partnerships and preferred provider relationships drive consistent revenue and high utilization.

• Commercial strategy aims to expand customer reach, focus on areas of expertise, and drive repeat business through strong execution.

• Emphasizes the importance of people, proactive solutions, and client engagement for consistent book-to-bill performance.